Biosynthetic Modularity Rules in the Bisintercalator Family of Antitumor Compounds

dc.contributor.author	Fernández Fernández, Javier
dc.contributor.author	Marín Fernández, Laura
dc.contributor.author	Álvarez Alonso, Raquel
dc.contributor.author	Redondo Blanco, Saúl
dc.contributor.author	Carvajal, Juan
dc.contributor.author	Villamizar Rodríguez, Germán
dc.contributor.author	Villar Granja, Claudio Jesús
dc.contributor.author	Lombó Brugos, Felipe
dc.date.accessioned	2014-09-01T09:07:18Z
dc.date.available	2014-09-01T09:07:18Z
dc.date.issued	2014
dc.identifier.citation	Marine Drugs, 12(5), p. 2668-2699 (2014); doi:10.3390/md12052668
dc.identifier.issn	1660-3397
dc.identifier.uri	http://hdl.handle.net/10651/28375
dc.description.sponsorship	Authors wish to thank grant EM15713 from CDTI (Centro para el Desarrollo Tecnológico e Industrial) from the Ministry of Economy and Competitiveness (Spain).
dc.format.extent	p. 2668-2699
dc.language.iso	eng
dc.relation.ispartof	Marine Drugs
dc.rights	CC Reconocimiento - No comercial - Sin obras derivadas 4.0 Internacional
dc.rights	© 2014 Javier Fernández et al.
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	WOS:000337160500018
dc.title	Biosynthetic Modularity Rules in the Bisintercalator Family of Antitumor Compounds
dc.type	journal article
dc.identifier.local	20142089
dc.identifier.doi	10.3390/md12052668
dc.relation.projectID	MINECO/EM15713
dc.relation.publisherversion	http://dx.doi.org/10.3390/md12052668
dc.rights.accessRights	open access

Este ítem está sujeto a una licencia Creative Commons